Richard W. Paul & Associates’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.29M Buy
4,776
+257
+6% +$76.5K 0.44% 61
2025
Q4
$1.49M Sell
4,519
-271
-6% -$91.8K 0.5% 48
2025
Q3
$1.65M Buy
4,790
+787
+20% +$238K 0.56% 39
2025
Q2
$1.25M Buy
4,003
+1,792
+81% +$685K 0.45% 51
2025
Q1
$1.16M Sell
2,211
-7
-0.3% -$3.58K 0.45% 49
2024
Q4
$1.12M Buy
2,218
+18
+0.8% +$10.2K 0.41% 66
2024
Q3
$1.29M Buy
2,200
+2
+0.1% +$1.13K 0.46% 58
2024
Q2
$1.12M Buy
2,198
+38
+2% +$18.6K 0.43% 55
2024
Q1
$1.07M Buy
2,160
+103
+5% +$52.4K 0.43% 57
2023
Q4
$1.08M Sell
2,057
-31
-1% -$16.5K 0.45% 57
2023
Q3
$1.05M Buy
2,088
+66
+3% +$32.5K 0.48% 54
2023
Q2
$972K Buy
2,022
+61
+3% +$29.8K 0.42% 66
2023
Q1
$927K Buy
1,961
+71
+4% +$34.3K 0.43% 67
2022
Q4
$1M Buy
+1,890
New +$1M 0.5% 55

Other funds holding UNH

Richard W. Paul & Associates's UNH Position: Q1 2026 in Review

Richard W. Paul & Associates increased its UnitedHealth (UNH) stake by 5.7% in Q1 2026, buying an estimated $76.5K and bringing the position to 4,776 shares worth $1.29M. The position accounts for 0.44% of the portfolio, ranked #61.

Richard W. Paul & Associates first reported a position in UNH in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.65M in Q3 2025. 3,021 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Richard W. Paul & Associates held 4,776 shares of UnitedHealth worth $1.29M as of Q1 2026.
  • Richard W. Paul & Associates bought 257 UnitedHealth shares in Q1 2026, an estimated $76.5K.
  • UnitedHealth made up 0.44% of Richard W. Paul & Associates's portfolio in Q1 2026, its #61 holding.
  • Richard W. Paul & Associates first reported a position in UnitedHealth in Q4 2022 and has held it in 14 quarters since.
  • Richard W. Paul & Associates's UnitedHealth position peaked at $1.65M in Q3 2025.
  • 3,021 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Richard W. Paul & Associates's 13F filing for Q1 2026, filed 13 May 2026.